The trademark application LONGEVERON was filed by Longeveron Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 17, 2020, and it was registered by office on August 24, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 13, 2022. A transfer of the trademark registration was recorded on October 20, 2022.
Goods And Services
The mark was filed in class 1 with Stem cells for research or scientific purposes.
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Stem cells for medical or veterinary use
Pharmaceutical and veterinary preparations for the treatment of frailty in humans and animals.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Research and development in the pharmaceutical and biotechnology fields
Research in the field of regenerative medicine
Scientific research services involving stem cells for medical purposes.
The mark was filed in class 44 with following description of goods: